Come meet some of Alberta’s top Medical Device, Diagnostic and HealthIT technologies and companies who are coming to connect with the investment community in Boston.
Metabolomic Technologies (MTI)– $25M Series B
Metabolomic Technologies Inc.(MTI) is engaged in using the new science of metabolomics to deliver innovative non-invasive diagnostics to the healthcare market. MTI’s flagship product, PolypDx™, is the first and only urine-based test with a high sensitivity for detecting adenomatous polyps, the precursor to colorectal cancer, thus providing doctors with a new tool for early screening and detection.
Salu Health Gauge– $0.5-2M Seed
Due to the global problem of hypertension – and related health problems – Salu created Health Gauge: a wearable to measure blood pressure and other important biometrics (including ECG, PPG, oxygen saturation, heart rate, and heart rate variability), along with an AI-based platform solution to support people in tracking, understanding, and managing their health. Currently, Health Gauge is working on new research proects including a project with the rehabilitation of stroke patients with Alberta Health Services (Glenrose Rehabilitation), and a study on eclampsia in developing nations with ICDDR,B (Bangladesh) supported by the Bill and Melinda Gates Foundation.
Tevosol– $20M Series A
Tevosol, Inc. is a medical device company developing the Ex-Vivo Organ Support System (EVOSS™) with the goal of increasing the number of organs available for transplantation worldwide. The EVOSS™ is a warm organ perfusion device consisting of a hardware platform with organ-specific single-use disposable cassettes for lungs, hearts, livers, and kidneys intended to preserve and assess viability of organs for transplant.
